FT. LAUDERDALE, Fla., Aug. 25, 2011 /PRNewswire/ — Life
Extension, a pioneer in the latest anti-aging research and
integrative health therapies, while offering superior quality,
research-backed dietary supplements, is actively recruiting
participants for a free clinical trial to study the effects of
natural supplements and an innovative medical therapy on Alzheimer’s
disease. Mild to moderate Alzheimer’s patients (as diagnosed by
their physician) are needed for a 17- to 18-week study. This study
requires weekly visits to the office of the study’s principal
investigator located in the Fort Lauderdale area. Participants will
receive blood tests, medical evaluations, blood pressure checks,
and study medication and supplements at no cost.
The objective of Life Extension’s new clinical trial is to
measure the effects of weekly injections of Enbrel® (generic
name etanercept), a commonly used medication for autoimmune
disorders such as rheumatoid arthritis, and nutritional supplements
that may help suppress the inflammatory factor implicated in the
neuronal degeneration of Alzheimer’s disease. Twenty million
Americans today are destined to contract Alzheimer’s disease, an
affliction that robs memory, intelligence and eventually the most
rudimentary cognitive abilities. The few medications currently
approved to treat Alzheimer’s symptoms produce only modest,
short-term effects. Some patients cannot tolerate them at all.
Dr. Steven Hirsch, Director of Clinical Research at Life
Extension, stated that “Up until now, a diagnosis of Alzheimer’s
disease meant one was destined to slowly be deprived of all
cognitive function, a condition that tops the list of aging
people’s disease fears. This is the first clinical trial sponsored
by Life Extension that will permit us to better understand
Alzheimer’s disease and how traditional medications, in conjunction
with nutri
‘/>”/>
